Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Liver Imaging

Focal type of peliosis hepatis

Gil-Sun Hong, Kyoung Won Kim, Jihyun An, Ju Hyun Shim, Jihun Kim, Eun Sil Yu

Clin Mol Hepatol. 2015;21(4):398-401. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.398

View: 8181 Download: 107 Web of Science: 4 Crossref: 6

Case Report

A case of primary hepatic actinomycosis: an enigmatic inflammatory lesion of the liver

Yeon Jung Ha, Ji Hyun An, Ju Hyun Shim, Eun Sil Yu, Jong Jae Kim, Tae Yong Ha, Han Chu Lee

Clin Mol Hepatol. 2015;21(1):80-84. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.80

View: 7920 Download: 103 Web of Science: 9 Crossref: 8

Original Article

Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma

Hyo Jeong Lee, Hyo Jeong Kang, Kang Mo Kim, Eun Sil Yu, Ki Hun Kim, Seung-Mi Kim, Tae Won Kim, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2015;21(1):60-70. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.60

View: 8398 Download: 128 Web of Science: 21 Crossref: 21

1 |

Viewed By 5605	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4826	MAFLD: How is it different from NAFLD?
Viewed By 4562	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3725	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3715	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 135	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 80	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Search